GPP

Great Point Partners Portfolio holdings

AUM $308M
1-Year Est. Return 183.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+183.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$240M
AUM Growth
+$85.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$16.7M
2
+$14M
3
+$11.6M
4
NKTR icon
Nektar Therapeutics
NKTR
+$9.93M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$6.79M

Top Sells

1
+$70M
2
+$20.5M
3
+$8.73M
4
AKBA icon
Akebia Therapeutics
AKBA
+$7.23M
5
EOLS icon
Evolus
EOLS
+$6.63M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMLX icon
1
Amylyx Pharmaceuticals
AMLX
$1.64B
$23.1M 9.65%
1,700,000
-300,000
RZLT icon
2
Rezolute
RZLT
$304M
$23M 9.62%
2,451,809
-581,653
NKTR icon
3
Nektar Therapeutics
NKTR
$2.05B
$17.1M 7.13%
+300,000
ZURA icon
4
Zura Bio
ZURA
$663M
$16.5M 6.9%
3,815,930
+645,736
SLNO icon
5
Soleno Therapeutics
SLNO
$2.02B
$15.2M 6.35%
+225,000
ASND icon
6
Ascendis Pharma
ASND
$14B
$14.9M 6.23%
+75,000
ABVX
7
Abivax
ABVX
$8.88B
$12.7M 5.32%
150,000
-1,141,617
APGE icon
8
Apogee Therapeutics
APGE
$5.14B
$12.1M 5.04%
+304,000
DNTH icon
9
Dianthus Therapeutics
DNTH
$3.71B
$10.5M 4.37%
+265,803
CYTK icon
10
Cytokinetics
CYTK
$7.84B
$8.24M 3.44%
150,000
IMVT icon
11
Immunovant
IMVT
$5.2B
$8.06M 3.37%
500,000
+237,824
XENE icon
12
Xenon Pharmaceuticals
XENE
$4.91B
$8.03M 3.35%
200,000
NGNE icon
13
Neurogene
NGNE
$357M
$7.74M 3.23%
446,814
-39,045
EPRX
14
Eupraxia Pharmaceuticals
EPRX
$448M
$7.08M 2.96%
+1,200,000
UPB
15
Upstream Bio Inc
UPB
$506M
$5.64M 2.36%
300,000
JBIO
16
Jade Biosciences
JBIO
$691M
$5.46M 2.28%
632,599
+134,545
IONS icon
17
Ionis Pharmaceuticals
IONS
$12.4B
$5.23M 2.19%
80,000
-420,000
AKRO
18
DELISTED
Akero Therapeutics
AKRO
$4.93M 2.06%
103,848
TSHA icon
19
Taysha Gene Therapies
TSHA
$1.24B
$4.91M 2.05%
1,500,000
CNTX icon
20
Context Therapeutics
CNTX
$291M
$4.54M 1.89%
4,683,711
PHVS icon
21
Pharvaris
PHVS
$1.78B
$3.87M 1.62%
+155,105
DBVT
22
DBV Technologies
DBVT
$1.15B
$3.79M 1.58%
378,594
+3,915
LEGN icon
23
Legend Biotech
LEGN
$3.74B
$3.7M 1.54%
113,460
-236,540
ORKA
24
Oruka Therapeutics
ORKA
$1.67B
$3.53M 1.47%
+183,330
UNCY icon
25
Unicycive Therapeutics
UNCY
$151M
$3.47M 1.45%
796,558
1
2